Upcoming Event

Targeting Post-Translational Modification in Cancer

  • May 28, 2026
  • 4:00 PM - 5:00 PM
  • 105 ZRC, MSKCC, 417 E. 68th St.

Event Details

Type
Molecular Pharmacology and Chemistry Program
Speaker(s)
Edward Tate, Ph.D., GSK Chair in Chemical Biology, Imperial College London & The Francis Crick Institute, Targeting Post-Translational Modification in Cancer
Open to
Public
Reception
Tea, 3:45 p.m.
Phone
(646) 888-3712
Sponsor
Beneysha Bolden
(646) 888-3712
boldenb@mskcc.org

Add To Your Calendar

Related News

Svetlana Mojsov promoted to Research Professor

Svetlana Mojsov, whose research led to the development of revolutionary obesity drugs, has been promoted. She is now Rockefeller’s Lulu Chow Wang and Robin Chemers Neustein Research Professor.

The neural basis of thought symbols identified for the first time

The brain activity that occurs during the act of drawing reveals fundamental neural properties and has implications for the improvement of brain-computer interfaces and the study of brain disorders.

New genomic approaches uncover surprising cellular dynamics of the aging brain

Two techniques—one for optics-free spatial mapping of tissue organization and the other for the enrichment of rare cell types—offer new ways to study aging and disease.

Related Events

Waves of Life: Programs, Stages, and Reversibility in Mammalian Aging

| CASPARY AUDITORIUM

Mapping Development with Microscopy

| 101 ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.

Designer DNA: Drug Therapy for Neurodegenerative Disease

| CASPARY AUDITORIUM